0001209191-21-046042.txt : 20210708
0001209191-21-046042.hdr.sgml : 20210708
20210708183525
ACCESSION NUMBER: 0001209191-21-046042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210706
FILED AS OF DATE: 20210708
DATE AS OF CHANGE: 20210708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manning Paul B
CENTRAL INDEX KEY: 0001494695
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 211081250
MAIL ADDRESS:
STREET 1: 200 GARRETT STREET SUITE S
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001576885
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364108129
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4435 NORTH FIRST STREET, SUITE 360
CITY: LIVERMORE
STATE: CA
ZIP: 94551
BUSINESS PHONE: 925-368-8508
MAIL ADDRESS:
STREET 1: 4435 NORTH FIRST STREET, SUITE 360
CITY: LIVERMORE
STATE: CA
ZIP: 94551
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-06
1
0001576885
Acumen Pharmaceuticals, Inc.
ABOS
0001494695
Manning Paul B
C/O ACUMEN PHARMACEUTICALS, INC.
427 PARK STREET
CHARLOTTESVILLE
VA
22902
0
0
1
0
Common Stock
2021-07-06
4
C
0
2950484
A
3040193
I
See footnote
Common Stock
2021-07-06
4
P
0
312500
16.00
A
3352693
I
See footnote
Common Stock
2021-07-06
4
C
0
657985
A
657985
I
See footnote
Series A-1 Preferred Stock
2021-07-06
4
C
0
1634515
0.00
D
Common Stock
1634515
0
I
See footnote
Series B Preferred Stock
2021-07-06
4
C
0
1315969
0.00
D
Common Stock
1315969
0
I
See footnote
Series B Preferred Stock
2021-07-06
4
C
0
657985
0.00
D
Common Stock
657985
0
I
See footnote
On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred
Stock") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of
the Issuer's common stock. The shares had no expiration date.
The securities are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust.
The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the
manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.
/s/ Katherine Denby, Attorney-in-Fact
2021-07-08